Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03142126Not ApplicableCompleted

Accelerated Ambulation After Vascular Access Closure Device

Role: collaborator

NCT03631940Not ApplicableCompleted

Umbilical Cord Milking in Non-Vigorous Infants

Role: collaborator

NCT03476980Not ApplicableUnknown

Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)

Role: collaborator

NCT03019367Not ApplicableCompleted

Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2

Role: collaborator

NCT00003123Phase 2Unknown

Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome

Role: lead

All 5 trials loaded